ViiV Healthcare Submits Regulatory Application to European Medicines Agency for Investigational Cabotegravir to Be Used in Combination With Rilpivirine as the First Monthly, Injectable Treatment for H
Go back to ViiV Healthcare Submits Regulatory Application to European Medicines Agency for Investigational Cabotegravir to Be Used in Combination With Rilpivirine as the First Monthly, Injectable Treatment for H| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 48.62 -1.27 (2.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.89 | 52 Week High | $45.58 | |||
| Open | $49.00 | 52 Week Low | $37.82 | |||
| Day High | $49.23 | P/E | N/A | |||
| Day Low | $48.54 | EPS | $0.00 | |||
| Volume | 2,173,381 | |||||
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 48.62 -1.27 (2.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.89 | 52 Week High | $45.58 | |||
| Open | $49.00 | 52 Week Low | $37.82 | |||
| Day High | $49.23 | P/E | N/A | |||
| Day Low | $48.54 | EPS | $0.00 | |||
| Volume | 2,173,381 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 27.91 -0.54 (1.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.45 | 52 Week High | $37.39 | |||
| Open | $28.02 | 52 Week Low | $28.25 | |||
| Day High | $28.15 | P/E | 16.92 | |||
| Day Low | $27.72 | EPS | $1.65 | |||
| Volume | 18,920,485 | |||||
